MA27416A1 - Cellules pulmonaires du rat des cotonniers pour la culture de virus - Google Patents

Cellules pulmonaires du rat des cotonniers pour la culture de virus

Info

Publication number
MA27416A1
MA27416A1 MA27878A MA27878A MA27416A1 MA 27416 A1 MA27416 A1 MA 27416A1 MA 27878 A MA27878 A MA 27878A MA 27878 A MA27878 A MA 27878A MA 27416 A1 MA27416 A1 MA 27416A1
Authority
MA
Morocco
Prior art keywords
cotton rat
virus culture
pulmonary cells
cells
pathogens
Prior art date
Application number
MA27878A
Other languages
English (en)
Inventor
Frederic R David
Michael E Tanner
Sudhir K Reddy
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of MA27416A1 publication Critical patent/MA27416A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0688—Cells from the lungs or the respiratory tract
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA27878A 2002-03-20 2004-09-28 Cellules pulmonaires du rat des cotonniers pour la culture de virus MA27416A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36601402P 2002-03-20 2002-03-20
US10/391,498 US7906311B2 (en) 2002-03-20 2003-03-18 Cotton rat lung cells for virus culture

Publications (1)

Publication Number Publication Date
MA27416A1 true MA27416A1 (fr) 2005-07-01

Family

ID=29553339

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27878A MA27416A1 (fr) 2002-03-20 2004-09-28 Cellules pulmonaires du rat des cotonniers pour la culture de virus

Country Status (17)

Country Link
US (1) US7906311B2 (fr)
EP (1) EP1517987B1 (fr)
KR (1) KR20050005426A (fr)
CN (1) CN1653172A (fr)
AT (1) ATE511397T1 (fr)
AU (1) AU2003265230B8 (fr)
BR (1) BRPI0308736B1 (fr)
CA (1) CA2479747C (fr)
CY (1) CY1111775T1 (fr)
DK (1) DK1517987T3 (fr)
HK (1) HK1070671A1 (fr)
MA (1) MA27416A1 (fr)
MX (1) MXPA04009050A (fr)
PT (1) PT1517987E (fr)
RU (1) RU2376370C2 (fr)
SI (1) SI1517987T1 (fr)
WO (1) WO2003102021A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
WO2008089094A2 (fr) * 2007-01-12 2008-07-24 The Board Of Trustees Of The University Of Illinois Cellules non simiennes permettant de développer le virus du syndrome dysgénésique et respiratoire du porc (prrs)
RU2496870C2 (ru) * 2011-02-15 2013-10-27 Государственное научное учреждение Прикаспийский зональный научно-исследовательский ветеринарный институт Российской академии сельскохозяйственных наук Способ получения эпителиоподобных клеток легкого плода буйволицы для культивирования вирусов
CN103893750B (zh) * 2012-12-31 2015-11-25 普莱柯生物工程股份有限公司 一种抗猪伪狂犬病、猪流感疫苗组合物及其应用
EP2978147B1 (fr) 2013-06-05 2018-10-17 LG Electronics Inc. Procédé et appareil de transmission d'informations d'état de canal dans un système de communication sans fil
CN103387604B (zh) * 2013-07-25 2015-04-15 中国农业科学院上海兽医研究所 鸡ibv s1蛋白的cd8+t细胞抗原表位多肽
CA2943816A1 (fr) 2014-04-03 2015-10-08 Boehringer Ingelheim Vetmedica, Inc. Vaccin contre le virus de la diarrhee epidemique porcine
CN108130316A (zh) * 2018-02-09 2018-06-08 天康生物股份有限公司 猪流行性腹泻病毒及其分离方法和应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1408437A (en) 1972-10-16 1975-10-01 C Vet Ltd Vaccines
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US5151267A (en) * 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
FR2693472B1 (fr) 1992-06-26 1994-12-23 Rhone Merieux Mutants du virus de la rhinotrachéite infectieuse bovine, délétés dans l'un des gènes des glycoprotéines mineures, vaccins préparés à partir de ces souches, méthodes de production et méthodes d'utilisation.
US5616326A (en) 1990-01-25 1997-04-01 The University Court Of The University Of Glasgow Recombinant canine adenovirus 2 (CAV-2)
CA2103460C (fr) 1991-06-06 2000-09-26 Gert Wensvoort Agent causal de la maladie mysterieuse du porc, compositions pour la vaccination et trousses diagnostiques
CA2076744C (fr) * 1991-08-26 2000-06-27 Danny W. Chladek Agent viral associe a la maladie mysterieuse du porc
DK0601062T4 (da) 1991-08-26 2001-03-14 Univ Minnesota SIRS-vaccine og diagnosefremgangsmåde
US6013638A (en) * 1991-10-02 2000-01-11 The United States Of America As Represented By The Department Of Health And Human Services Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
JP2521226B2 (ja) 1993-01-28 1996-08-07 株式会社微生物化学研究所 犬用多種混合ワクチン
SK98695A3 (en) 1993-02-08 1996-11-06 Bayer Ag Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
EP0676467B1 (fr) 1994-04-11 2001-10-04 Akzo Nobel N.V. Souches vaccinales Européennes du virus du syndrome respiratoire réproducteur porcin (PRRSV)
DE69632658T2 (de) 1995-03-14 2005-06-09 Akzo Nobel N.V. Expression in der selben Zelle von Polypeptide vom schweinen reproduktiven und respiratorischen Syndrom
AU705186B2 (en) * 1995-06-12 1999-05-20 Kansas State University Research Foundation Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection
FR2750865B1 (fr) 1996-06-27 1998-12-04 Rhone Merieux Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2
US5976537A (en) 1996-07-02 1999-11-02 The United States Of America As Represented By The Secretary Of Agriculture Porcine reproductive and respiratory syndrome vaccine
US6090393A (en) 1996-07-03 2000-07-18 Merial Recombinant canine adenoviruses, method for making and uses thereof
FR2751228B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
FR2751224B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
FR2751227B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
FR2751226B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
FR2751229B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
JP2950273B2 (ja) 1997-01-27 1999-09-20 株式会社微生物化学研究所 ウシロタウイルス病ワクチン
US6368603B1 (en) 1997-03-05 2002-04-09 Merial Limited Lyme combination compositions and uses
AUPO856097A0 (en) 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
US6391314B1 (en) 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
US6517843B1 (en) 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2781159B1 (fr) 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
US6492343B1 (en) 1998-04-15 2002-12-10 University Of Saskatchewan Porcine adenovirus type 3 genome
CA2337965C (fr) 1998-07-31 2009-12-15 Akzo Nobel N.V. Virus herpetique equin attenue
US20020037274A1 (en) * 1998-10-26 2002-03-28 Angelica Williams Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mutants
CA2440933A1 (fr) 1998-12-22 2000-06-22 Pfizer Products Inc. Un clone d'adnc infectieux du virus nord-americain du syndrome dysgenesique respiratoire porcin (sdrp) et ses utilisations
FR2789695B1 (fr) 1999-02-11 2003-03-07 Merial Sas Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6379676B2 (en) 1999-03-10 2002-04-30 Anitox Corporation Enhancing immune response in animals
CA2365911A1 (fr) 1999-04-09 2000-10-19 Schering-Plough Ltd. Adenovirus recombinants et mutants derives de l'adenovirus type 1 bovin
US6497883B1 (en) 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
ES2170622B1 (es) 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
EP1129722A1 (fr) 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh Mutants gM-négatifs de l'EHV
WO2001083737A2 (fr) 2000-05-03 2001-11-08 University Of Guelph Vaccin d"adenovirus porcin
JP2003533989A (ja) 2000-05-24 2003-11-18 メリアル ブタ生殖・呼吸症候群ウィルス（ｐｒｒｓｖ）の組換えポックスウィルスワクチン
US20040191170A1 (en) * 2001-04-03 2004-09-30 Mond James J. Animal model for enteric pathogens

Also Published As

Publication number Publication date
KR20050005426A (ko) 2005-01-13
WO2003102021A2 (fr) 2003-12-11
CA2479747A1 (fr) 2003-12-11
DK1517987T3 (da) 2011-07-11
EP1517987B1 (fr) 2011-06-01
WO2003102021A3 (fr) 2004-09-30
AU2003265230B8 (en) 2009-06-18
EP1517987A4 (fr) 2006-12-20
CA2479747C (fr) 2010-10-19
BRPI0308736B1 (pt) 2016-04-05
CY1111775T1 (el) 2015-10-07
AU2003265230B2 (en) 2009-02-19
BR0308736A (pt) 2005-08-16
ATE511397T1 (de) 2011-06-15
AU2003265230A1 (en) 2003-12-19
EP1517987A2 (fr) 2005-03-30
CN1653172A (zh) 2005-08-10
US7906311B2 (en) 2011-03-15
RU2376370C2 (ru) 2009-12-20
RU2004130864A (ru) 2005-05-10
HK1070671A1 (en) 2005-06-24
US20030219460A1 (en) 2003-11-27
PT1517987E (pt) 2011-07-12
MXPA04009050A (es) 2005-06-08
SI1517987T1 (sl) 2011-09-30

Similar Documents

Publication Publication Date Title
CY1111775T1 (el) Πνευμονικα κυτταρα βαμβακοαρουραιου για καλλιεργεια ιου
HK1080507A1 (en) Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
CY1110716T1 (el) Πολλαπλασιασμος ιων εντος κυτταροκαλλιεργειας
MY146518A (en) Methods to culture circovirus.
SG171577A1 (en) Methods for producing yeast-based vaccines
WO2006070370A3 (fr) Systemes de culture de cellules souches
SE0201328D0 (sv) Hematopoietic differentiation of human embryonic stem cells
NZ569543A (en) Means and methods for influencing the stability of antibody producing cells
UA92157C2 (ru) Способ продуцирования гормона роста
RU2007148138A (ru) Способ формирования зуба, зубной ряд и способ формирования ткани
WO2006127585A3 (fr) Transduction de cellules primaires
DK1720979T3 (da) Anvendelse af et serumfrit celledyrkningsmedium til fremstilling af IL-18BP I pattedyrceller
ATE465637T1 (de) Cysteingranulate und ihre verwendung als wachstumsstimulanzien für bifidobaceterium animalis lactis
TW200617165A (en) Process for preparing a conditioned medium of astrocyte-like cells
DE602006014534D1 (de) Herstellung und verwendung von basalmembranpartikeln
WO2007075796A3 (fr) Systemes de maturation de follicules specifiques a l'etape
WO2003100010A3 (fr) Croissance et maintenance de cellules progenitrices sans cytokine
ATE305718T1 (de) Neues verfahren zur herstellung und auswahl von transgenen flachspflanzen und leinsamen
DK1238057T3 (da) Fremgangsmåde til produktion af vedhæftende dyreceller
EP1309342A4 (fr) Production de papillomavirus humain chimerique
DE60007991D1 (de) Verwendung des proteins uk 114 zur verhinderung der abstossung eines transplantierten organs
UA36386A (uk) Камера для культивування клітин
MY171579A (en) Construction of tissue-engineered bone using ceramic scaffold and fibrin